POXEL |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.628 EUR | +0.32% |
|
-7.10% | +13.97% |
| Apr. 11 | Poxel: CDC falls below the 10% threshold | CF |
| Feb. 15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| POXEL | Bio Therapeutic Drugs | +0.32% | -7.10% | +13.97% | -5.14% | -91.19% | 26.35M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- POXEL Stock
- Charts Poxel
- Comparison Chart
